fluorodeoxyglucose f18 has been researched along with chronic COVID syndrome in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 13 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cammilleri, S; Dudouet, P; Eldin, C; Guedj, E; Jacquier, A; Raoult, D | 1 |
Barthelemy, F; Cammilleri, S; Campion, JY; Ceccaldi, M; Guedj, E; Horowitz, T | 1 |
Farid, K; Hugon, J; Msika, EF; Paquet, C; Queneau, M; Sanchez Ortiz, M | 1 |
Buonsenso, D; Cocciolillo, F; De Rose, C; Di Giuda, D; Morello, R; Valentini, P | 1 |
Albert, NL; Barthel, H; Boellaard, R; Brendel, M; Cecchin, D; Ekmekcioglu, O; Fraioli, F; Guedj, E; Morbelli, S; Semah, F; Tolboom, N; Traub-Weidinger, T; van Berckel, B; van de Weehaeghe, D; Verger, A | 1 |
Audhoe, RS; Chen, LL; de Boer, SM; de Geus-Oei, LF; Smit, F; van de Burgt, A; van Velden, FHP | 1 |
Bregeon, F; Cammilleri, S; Dudouet, P; Guedj, E; Million, M; Raoult, D; Tissot-Dupont, H | 1 |
Barthelemy, F; Bregeon, F; Cammilleri, S; Campion, JY; Ceccaldi, M; Dudouet, P; Eldin, C; Guedj, E; Guis, S; Habert, P; Kaphan, E; Million, M; Raoult, D; Tissot-Dupont, H | 1 |
Aghemo, A; Cecconi, M; Chiola, S; Chiti, A; Ciccarelli, M; Gelardi, F; Morbelli, S; Morelli, P; Sollini, M | 1 |
Fontana, IC; Pellerin, L; Souza, DG; Souza, DO; Zimmer, ER | 1 |
Ceccaldi, M; Eldin, C; Guedj, E; Hautefort, C; Kas, A; Lazarini, F; Morbelli, S; Radulesco, T; Salmon-Ceron, D | 1 |
Farid, K; Hugon, J; Msika, EF; Paquet, C; Queneau, M | 1 |
Bosdure, E; Cammilleri, S; Campion, JY; Chabrol, B; Guedj, E; Lepine, A; Luciani, L; Morand, A | 1 |
13 other study(ies) available for fluorodeoxyglucose f18 and chronic COVID syndrome
Article | Year |
---|---|
Aortic
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Retrospective Studies; SARS-CoV-2 | 2021 |
The impact of COVID-19 lockdown on brain metabolism.
Topics: Aged; Aged, 80 and over; Brain; COVID-19; Emotions; Exercise; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Motor Cortex; Nerve Net; Pandemics; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Quarantine; Radiopharmaceuticals; Retrospective Studies; Social Isolation; Somatosensory Cortex | 2022 |
Cognitive decline and brainstem hypometabolism in long COVID: A case series.
Topics: Brain; Brain Stem; Cognitive Dysfunction; COVID-19; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals | 2022 |
Orbito-Frontal Cortex Hypometabolism in Children With Post-COVID Condition (Long COVID): A Preliminary Experience.
Topics: Brain; Child; COVID-19; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome | 2022 |
2-[
Topics: Brain; COVID-19; Fluorodeoxyglucose F18; Humans; Neuroimaging; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals | 2022 |
Investigating the potential added value of [ 18 F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Myalgia; Positron Emission Tomography Computed Tomography; Post-Acute COVID-19 Syndrome; Proof of Concept Study; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Topics: Anosmia; Brain; COVID-19; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pain; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals | 2021 |
Topics: Brain; COVID-19; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Retrospective Studies; SARS-CoV-2 | 2021 |
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study.
Topics: Adult; Case-Control Studies; COVID-19; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals; SARS-CoV-2 | 2021 |
About the source and consequences of
Topics: Brain; COVID-19; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2021 |
Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Memory Disorders; Olfaction Disorders; Olfactory Bulb; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals | 2021 |
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex.
Topics: Activities of Daily Living; Brain; Cognition; Cognitive Dysfunction; COVID-19; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2022 |
Similar patterns of [
Topics: Brain; Child; COVID-19; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Retrospective Studies; SARS-CoV-2 | 2022 |